擦亮您的眼:药盒上有这10个字,别乱吃!

2016-08-22 佚名 药评中心 公众号

1肝炎患者:避免使用“氨”“酚”氨酚黄那敏颗粒、氨酚待因片、酚麻美敏咀嚼片中的“氨酚”和“酚”,指该药品中含有对乙酰氨基酚。对乙酰氨基酚用于治疗由感冒引起的发热、头痛、周身四肢酸痛等症状。对乙酰氨基酚,只是一种弱的环氧酶抑制剂,无抗炎活性。一次或短期治疗剂量的对乙酰氨基酚,通常不会出现服用其它非甾体类抗炎药(阿司匹林、布洛芬、吲哚美辛、双氯芬酸钠等)后的胃肠道刺激作用、糜烂和出血。对乙酰氨基酚最严

1
肝炎患者:避免使用“氨”“酚”
氨酚黄那敏颗粒、氨酚待因片、酚麻美敏咀嚼片中的“氨酚”和“酚”,指该药品中含有对乙酰氨基酚。对乙酰氨基酚用于治疗由感冒引起的发热、头痛、周身四肢酸痛等症状。

对乙酰氨基酚,只是一种弱的环氧酶抑制剂,无抗炎活性。一次或短期治疗剂量的对乙酰氨基酚,通常不会出现服用其它非甾体类抗炎药(阿司匹林、布洛芬、吲哚美辛、双氯芬酸钠等)后的胃肠道刺激作用、糜烂和出血。

对乙酰氨基酚最严重的不良反应,是可致命的、剂量依赖性的肝坏死,也会发生肾小管坏死和低血糖昏迷。因此,病毒性肝炎患者、严重肝肾功能不全者禁用对乙酰氨基酚。

市场销售的复方感冒药中多数含有对乙酰氨基酚,患者服用感冒药是一定要看清是否含有对乙酰氨基酚,避免重复用药。

2
癫痫患者:禁用“烷胺”

复方氨酚烷胺片(感康)、氨酚烷胺咖敏胶囊中的“烷胺”,指该药品中含有金刚烷胺。金刚烷胺用于预防和治疗A型流感病毒所引起的呼吸道感染,也用于帕金森病。

金刚烷胺最常见的副作用是与用量关系不大的胃肠和中枢神经系统反应,包括神经过敏、头轻、不易集中精神、失眠和食欲消失或恶心。

金刚烷胺可使原有的癫痫发作和精神症状恶化。复方感冒药中的抗组胺药氯苯那敏(扑尔敏)等也可加强金刚烷胺的神经毒性。因此,癫痫患者应禁用金刚烷胺,1岁以内的儿童应禁用含金刚烷胺的成人感冒药。


3
司机:别吃“扑”“敏”“苯”“明”

美扑伪麻片、氨酚伪麻那敏片中的“扑”和“敏”,指该药品中含有氯苯那敏(扑尔敏);氨麻苯美片、酚明伪麻片中的“苯”和“明”,指该药中含有苯海拉明。氯苯那敏、苯海拉明均为常见的抗过敏药物,可缓解打喷嚏、流鼻涕等感冒症状。

氯苯那敏、苯海拉明具有一定的中枢神经抑制性和抗胆碱作用,可引起嗜睡、疲劳、乏力等不良反应。用药期间,不得驾驶车、船或操作危险的机器,司机最好别吃。


4
高血压、冠心病患者:不宜用“麻”

美扑伪麻片、伪麻那敏胶囊、美愈伪麻胶囊中的“麻”,指该药品中含有伪麻黄碱。伪麻黄碱可收缩上呼吸道毛细血管,消除鼻咽部黏膜充血、肿胀、减轻鼻塞症状。

伪麻黄碱还具有促进去甲肾上腺素释放的作用,可引起高血压心律失常、心脏病发作、中风和死亡。严重的高血压、冠心病、脑血管病、服用单胺氧化酶抑制剂者禁用含有伪麻黄碱的复方感冒药。

需要提醒的是,高血压和冠心病患者也不宜服用含有麻黄的中成药。如连花清瘟胶囊,感冒软胶囊,疏风定痛丸,风寒感冒颗粒;半夏糖浆,急支糖浆,复方川贝精胶囊,鹭鸶咳丸,通宣理肺丸;正天丸,鼻炎康片等。


5
痰多患者:慎服“美”

氨酚美伪麻片、美扑伪麻片中的“美”,指该药品中含有右美沙芬。右美沙芬是临床常用的中枢性镇咳药,用于治疗由感冒引起的干咳症状。

慢性支气管炎、肺炎患者痰多时应慎用右美沙芬或含本成分的复方感冒药。因为右美沙芬的中枢镇咳作用可能影响痰液排出、堵塞呼吸道。

另外,右美沙芬可引起头晕、头痛、嗜睡、易激动等不良反应,服药期间不得驾驶机、车、船、从事高空作业、机械作业及操作精密仪器。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=102482, encodeId=fcbd10248200, content=实用的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a301931826, createdName=tundra, createdTime=Tue Aug 23 07:31:00 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=102403, encodeId=79bd1024035a, content=很好的知识点!, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160821/IMG57B9667502B1F9208.jpg, createdBy=7a291940143, createdName=茶马古道, createdTime=Mon Aug 22 22:44:00 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=102237, encodeId=e39010223eef, content=学习了,了解了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Aug 22 10:55:00 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=102234, encodeId=065b1022341a, content=学习了,增加新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Aug 22 10:54:00 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=102168, encodeId=6396102168f5, content=很实用,码一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a3e1928208, createdName=顾小北大魔王, createdTime=Mon Aug 22 09:51:00 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=102170, encodeId=54571021e049, content=学习了!不错的知识!, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160821/IMG57B9667502B1F9208.jpg, createdBy=7a291940143, createdName=茶马古道, createdTime=Mon Aug 22 09:51:00 CST 2016, time=2016-08-22, status=1, ipAttribution=)]
    2016-08-23 tundra

    实用的文章

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=102482, encodeId=fcbd10248200, content=实用的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a301931826, createdName=tundra, createdTime=Tue Aug 23 07:31:00 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=102403, encodeId=79bd1024035a, content=很好的知识点!, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160821/IMG57B9667502B1F9208.jpg, createdBy=7a291940143, createdName=茶马古道, createdTime=Mon Aug 22 22:44:00 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=102237, encodeId=e39010223eef, content=学习了,了解了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Aug 22 10:55:00 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=102234, encodeId=065b1022341a, content=学习了,增加新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Aug 22 10:54:00 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=102168, encodeId=6396102168f5, content=很实用,码一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a3e1928208, createdName=顾小北大魔王, createdTime=Mon Aug 22 09:51:00 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=102170, encodeId=54571021e049, content=学习了!不错的知识!, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160821/IMG57B9667502B1F9208.jpg, createdBy=7a291940143, createdName=茶马古道, createdTime=Mon Aug 22 09:51:00 CST 2016, time=2016-08-22, status=1, ipAttribution=)]
    2016-08-22 茶马古道

    很好的知识点!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=102482, encodeId=fcbd10248200, content=实用的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a301931826, createdName=tundra, createdTime=Tue Aug 23 07:31:00 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=102403, encodeId=79bd1024035a, content=很好的知识点!, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160821/IMG57B9667502B1F9208.jpg, createdBy=7a291940143, createdName=茶马古道, createdTime=Mon Aug 22 22:44:00 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=102237, encodeId=e39010223eef, content=学习了,了解了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Aug 22 10:55:00 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=102234, encodeId=065b1022341a, content=学习了,增加新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Aug 22 10:54:00 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=102168, encodeId=6396102168f5, content=很实用,码一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a3e1928208, createdName=顾小北大魔王, createdTime=Mon Aug 22 09:51:00 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=102170, encodeId=54571021e049, content=学习了!不错的知识!, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160821/IMG57B9667502B1F9208.jpg, createdBy=7a291940143, createdName=茶马古道, createdTime=Mon Aug 22 09:51:00 CST 2016, time=2016-08-22, status=1, ipAttribution=)]
    2016-08-22 知难而进

    学习了,了解了解

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=102482, encodeId=fcbd10248200, content=实用的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a301931826, createdName=tundra, createdTime=Tue Aug 23 07:31:00 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=102403, encodeId=79bd1024035a, content=很好的知识点!, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160821/IMG57B9667502B1F9208.jpg, createdBy=7a291940143, createdName=茶马古道, createdTime=Mon Aug 22 22:44:00 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=102237, encodeId=e39010223eef, content=学习了,了解了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Aug 22 10:55:00 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=102234, encodeId=065b1022341a, content=学习了,增加新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Aug 22 10:54:00 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=102168, encodeId=6396102168f5, content=很实用,码一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a3e1928208, createdName=顾小北大魔王, createdTime=Mon Aug 22 09:51:00 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=102170, encodeId=54571021e049, content=学习了!不错的知识!, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160821/IMG57B9667502B1F9208.jpg, createdBy=7a291940143, createdName=茶马古道, createdTime=Mon Aug 22 09:51:00 CST 2016, time=2016-08-22, status=1, ipAttribution=)]
    2016-08-22 知难而进

    学习了,增加新知识

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=102482, encodeId=fcbd10248200, content=实用的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a301931826, createdName=tundra, createdTime=Tue Aug 23 07:31:00 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=102403, encodeId=79bd1024035a, content=很好的知识点!, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160821/IMG57B9667502B1F9208.jpg, createdBy=7a291940143, createdName=茶马古道, createdTime=Mon Aug 22 22:44:00 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=102237, encodeId=e39010223eef, content=学习了,了解了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Aug 22 10:55:00 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=102234, encodeId=065b1022341a, content=学习了,增加新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Aug 22 10:54:00 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=102168, encodeId=6396102168f5, content=很实用,码一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a3e1928208, createdName=顾小北大魔王, createdTime=Mon Aug 22 09:51:00 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=102170, encodeId=54571021e049, content=学习了!不错的知识!, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160821/IMG57B9667502B1F9208.jpg, createdBy=7a291940143, createdName=茶马古道, createdTime=Mon Aug 22 09:51:00 CST 2016, time=2016-08-22, status=1, ipAttribution=)]
    2016-08-22 顾小北大魔王

    很实用,码一下

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=102482, encodeId=fcbd10248200, content=实用的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a301931826, createdName=tundra, createdTime=Tue Aug 23 07:31:00 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=102403, encodeId=79bd1024035a, content=很好的知识点!, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160821/IMG57B9667502B1F9208.jpg, createdBy=7a291940143, createdName=茶马古道, createdTime=Mon Aug 22 22:44:00 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=102237, encodeId=e39010223eef, content=学习了,了解了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Aug 22 10:55:00 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=102234, encodeId=065b1022341a, content=学习了,增加新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Aug 22 10:54:00 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=102168, encodeId=6396102168f5, content=很实用,码一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a3e1928208, createdName=顾小北大魔王, createdTime=Mon Aug 22 09:51:00 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=102170, encodeId=54571021e049, content=学习了!不错的知识!, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160821/IMG57B9667502B1F9208.jpg, createdBy=7a291940143, createdName=茶马古道, createdTime=Mon Aug 22 09:51:00 CST 2016, time=2016-08-22, status=1, ipAttribution=)]
    2016-08-22 茶马古道

    学习了!不错的知识!

    0

相关资讯

不可空腹服用的药物清单

1、非甾体类抗炎药常见的非甾体抗炎药主要包括萘普生、阿司匹林等。其中萘普生可用于头痛、关节炎和月经所引起的疼痛。阿司匹林除止痛外,在医生指导下使用,还能预防潜在的心脏病和缺血性卒中的再次发作。但上述药物对胃肠存在一定刺激,因此饭后服用可降低胃肠出血等不良反应的风险。还需要注意的是,有胃病或肾不好的人,一定要请医生帮你选药。药物应从最小剂量开始使用,并且疼痛症状明显加重或出现新的疼痛症状,以及连续用

BMC Cancer:警惕!孕期药物化疗或影响所生女儿未来的生育能力

图片摘自:www.sundaypost.com近日,一项刊登于国际杂志BMC Cancer上的报告称,女性怀孕期间进行化疗或会影响未出生女儿将来的生育能力。文章中研究者在实验室中研究发现,一种名为依托泊甙的药物或许能够损伤小鼠卵巢组织的发育。依托泊苷是一种细胞周期特异性抗肿瘤药物,其可以阻碍癌细胞DNA的修复。 这种药物所影响的特异性细胞名为生殖细胞,其可以产生卵细胞,研究者表示他们需要后期

药物开发失败的概率:生物标记物指导的试验设计

本期Nature Reviews Drug Discovery发表了来自Genentech, Inc.公司Michael J. Townsend 和Joseph R. Arron的评论文章。文章讲到药物的候选分子可能因为各种各样的原因导致临床开发的失败,但是生物标记物指导的临床试验能够降低失败的风险。不论临床试验是否成功,生物标记物的指导能够让我们可以更好的理解和解释临床试验的结果。作者也引用了最

上海交通大学药学院朱建伟院长:自主创新是生物药物研发的根本道路

生物类药物发展现状自2000年以来,生物药物市场平均每年以10%以上的增长率发展,这一趋势将持续到2020年甚至到更长的时间。最近生物药物市场最畅销的前10种药物中,大概有7~8个是生物类药物,其中大部分是抗体药物。由此可知,生物类药物(抗体药物)主导了药物发展趋向。从最近15年中国单抗药物申报数量趋势图来看,从2000年到2010年,每年申报数量不超过5个,这一时期生物类药物发展缓慢;从

药物对癌细胞荧光示踪一体化研究实现

中科院长春光机所副研究员曾庆辉等人利用绿色荧光碳点(CDs)做药物释放载体,实现了药物对癌细胞的选择性释放、荧光示踪一体化的研究。成果发表于《材料化学B》。研究为荧光碳纳米点在癌症诊断治疗技术方面的潜在临床应用拓展了新的研究方向。癌症化疗药物对人体正常细胞有一定的毒害性,因此癌症药物的选择性释放,一直以来都是生物医学的重大研究方向。曾庆辉等人选择肝癌细胞作为目标,进行CDs的药物选择性释放、荧光示

超强盘点:那些可能引起血压升高的药物

药源性高血压是指由于药物本身的药理作用和(或)毒理作用,药物之间相互作用,或用药方法不当导致患者血压升高,或者高血压患者在使用药物治疗的过程中出现血压进一步升高,或原本已降至正常的血压出现反跳,属继发性高血压 [1]。药源性高血压并不少见,老年人由于各脏器的组织结构和生理功能出现退行性改变,对血压的调节能力下降,同时常伴有多种基础疾病,治疗时合并用药也颇多。对钠敏感的人群、心肾功能不全的患者应